Germany Exhibition Health (000813): Involved In Industrial Hemp 300 Million "Entry" Sincerity Was Asked

Prior to the industrial cannabis hot stocks, Germany exhibition health (000813, SZ) received the inquiry report of the Shenzhen Stock Exchange in May 21st.

In March of this year, according to the framework agreement, Han Zhong Group handed down its 25% stake in hemp investment to the health of Germany exhibition, and Germany paid health cooperation to Han Zhong Group to pay 400 million yuan in cooperation.

Among them, 100 million yuan will be paid to Han Zhong Group, and the remaining 300 million yuan will be used and managed by the two sides of the bank using a co management account.

In the inquiry letter, the Shenzhen Stock Exchange asked for the payment time and storage method of the remaining cooperation fund 300 million yuan. The two parties agreed on the conditions for using the cooperation sincerity, and whether it would be beneficial to protect the interests of the company and the legitimate rights and interests of the minority shareholders.

At the same time, the Shenzhen Stock Exchange also inquired about the 15 reasons for the great difference between the operating income and the selling expenses of the German annual health report.

In 2019, when the concept of industrial cannabis was hot, Tak was in good health and signed a framework agreement on equity purchase and comprehensive strategic cooperation between the company and Han Zhong Business Management Group Co., Ltd. and HMA Investment Group Co., Ltd. in March 8th.

As for the question of sincerity and sincerity, German exhibition health has received the letter of concern as early as March. It mainly involves the payment progress of a total of 400 million sincerity funds, and whether the proportion of sincerity payment is in line with general commercial practices.